Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
Malagari K, Pomoni M, Spyridopoulos TN, Moschouris H, Kelekis A, Dourakis S, Alexopoulou E, Koskinas J, Angelopoulos M, Kornezos J, Pomoni A, Tandeles S, Marinis A, Rizos S, Kelekis D. Malagari K, et al. Among authors: dourakis s. Cardiovasc Intervent Radiol. 2011 Aug;34(4):774-85. doi: 10.1007/s00270-010-0044-3. Epub 2010 Dec 24. Cardiovasc Intervent Radiol. 2011. PMID: 21184228
Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, Moschouris H, Emmanouil E, Rizos S, Kelekis D. Malagari K, et al. Among authors: dourakis s. Cardiovasc Intervent Radiol. 2010 Jun;33(3):541-51. doi: 10.1007/s00270-009-9750-0. Epub 2009 Nov 24. Cardiovasc Intervent Radiol. 2010. PMID: 19937027 Clinical Trial.
Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead.
Pomoni M, Malagari K, Moschouris H, Spyridopoulos TN, Dourakis S, Kornezos J, Kelekis A, Thanos L, Chatziioanou A, Hatjimarkou I, Marinis A, Koskinas J, Kelekis D. Pomoni M, et al. Among authors: dourakis s. Hepatogastroenterology. 2012 May;59(115):820-5. doi: 10.5754/hge11347. Hepatogastroenterology. 2012. PMID: 22024228
Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30-60 μm: Results from a Single-Centre Prospective Phase II Trial.
Malagari K, Moschouris H, Kiakidis T, Harward S, Kelekis A, Vrakas S, Koundouras D, Filipiadis D, Glantzounis G, Emmanouil E, Chatziioannou A, Vergadis V, Elefsiniotis I, Koskinas J, Dourakis S, Kelekis N. Malagari K, et al. Among authors: dourakis s. Cardiovasc Intervent Radiol. 2019 Nov;42(11):1551-1562. doi: 10.1007/s00270-019-02260-3. Epub 2019 Jul 18. Cardiovasc Intervent Radiol. 2019. PMID: 31321482 Clinical Trial.
Hepatic granulomas: a 6-year experience in a single center in Greece.
Dourakis SP, Saramadou R, Alexopoulou A, Kafiri G, Deutsch M, Koskinas J, Archimandritis AJ. Dourakis SP, et al. Eur J Gastroenterol Hepatol. 2007 Feb;19(2):101-4. doi: 10.1097/01.meg.0000243882.09820.d2. Eur J Gastroenterol Hepatol. 2007. PMID: 17272993
146 results